Skip to content
Trial Eligibility
Menu

A Novel Surgical Irrigation Solution in Post-Mastectomy Reconstruction: Evaluating Xperience™

NCT06649890

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Goal of the Clinical Trial: The purpose of this clinical trial is to learn whether Xperience™ surgical irrigation solution is more effective than a standard dilute povidone-iodine solution in reducing surgical site infections (SSIs) following implant-based breast reconstruction in female patients, aged 18 and older. It will also assess the safety and overall surgical outcomes when using Xperience™ compared to povidone-iodine. Main Questions the Study Aims to Answer: Does the use of Xperience™ decrease the incidence of surgical site infections compared to povidone-iodine?

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Surgical Site Infection
  • Surgical Complication
  • Implant Infection
  • Implant Complication

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 years and older
Sex
Female
Healthy volunteers
Accepted
Sponsor
University of North Carolina, Chapel Hill
Last updated on ClinicalTrials.gov
August 7, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

North Carolina · 1

  • University of North Carolina at Chapel Hill Hospital · Chapel Hill, NC

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.